Clinical Microbiology Reviews

Table of contents | Volume 28 Issue 3 | July 2015

Click here to view the table of contents and access full text – If prompted, enter your QH payroll number and surname.

– Whole genome sequencing in outbreak analysis.
– The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.
– Backs against the wall: novel and existing strategies used during the 2014-15 Ebola virus outbreak.
– Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.
– Cerebral toxocariasis: silent progression to neurodegenerative disorders?
– Global epidemiology of campylobacter infection.
– Diversity and evolution in the genome of clostridium difficile
– Respiratory infections in the US military: recent experience and control.
– Blood groups in infection and host susceptibility.
– Pneumococcal capsules and their types: past, present and future.

If you are unable to access this content, please contact the library. (QH staff only)


What’s in your landscape? Plants can alter West Nile virus risk

EurekAlert 1 July 2015

A new study looks at how leaf litter in water influences the abundance of Culex pipiens mosquitoes, which can transmit West Nile virus to humans, domestic animals, birds and other wildlife.

The study found that different species of leaf litter in standing water influence where Culex pipiens mosquitoes deposit their eggs, how quickly the larvae grow, how big they get and whether they survive to adulthood. Because the mosquitoes feed on bacteria that grow on leaf litter, the team also measured how native and non-native leaf species influenced bacterial abundance and diversity.

The study is reported in the journal Parasites and Vectors.

Request a copy of the article (QH staff only)

Vanderbilt research could lead to vaccines and treatment for dengue virus

EurekAlert 2 July 2015

Researchers at Vanderbilt University and the National University of Singapore have determined the structure of a human monoclonal antibody which, in an animal model, strongly neutralizes a type of the potentially lethal dengue virus.

The finding, reported today July 2 in the journal Science, could lead to the first effective therapies and vaccines against dengue, a complex of four distinct but related mosquito-borne viruses that infect about 390 million people a year and which are a leading cause of illness and death in the tropics.

Request a copy of the article (QH staff only)

Collapse at Clarence Colliery at Lithgow ‘equivalent to giant oil spill’, wilderness foundation says

ABC News 3 July 2015

Conservationists believe the collapse of a dividing wall at a coal mine in Lithgow is “equivalent to a giant oil spill”.

The NSW Environmental Protection Authority (EPA) began investigating the incident yesterday and said at least 150 metres of the Wollangambe River was “showing signs of impact”.

The cause for the collapse at the Clarence Colliery is still unknown, as is the overall damage that might be done to the Greater Blue Mountains World Heritage Area, the boundary of which is within two kilometres of the mine.

Drug company denies claims of stifling criticism as deadline looms for Hendra vaccine permit

ABC News 3 July 2015

Horse owners and vets are demanding the manufacturer of the Hendra vaccine release more information about the drug’s safety record, amidst claims the company is trying to stifle criticism.

The company, Zoetis, has strongly denied the claims and urged horse owners to stop speculating about the safety behind the drug, which was developed by an award-winning CSIRO research team.


Champix probe: Queensland coroner reopens investigation into anti-smoking drug’s possible link to 22yo man’s suicide

ABC News 3 July 2015

The Queensland coroner has reopened an investigation into the death of a 22-year-old Brisbane man who committed suicide just days after starting medication to quit smoking.

Timothy Oldham left a box of anti-smoking drug Champix next to his suicide tape recording when he died in 2013.

He began taking the drug just eight days prior to taking his life.

As part of an investigation, the Queensland coroner has now begun reviewing all suicides in Australia where the person had taken Champix.

Superbugs, antibiotic resistance and the Queensland team fighting back

Brisbane Times 2 July 2015

South-east Queensland is leading the fight to protect our final defense against deadly superbugs.

The Australian government launched the country’s first strategy to address antimicrobial resistance (AMR) last month, labelling it an “urgent global health priority”.

The strategy set out plans to raise awareness of AMR, co-ordinate research to attack the problem and cut down on the overuse of antibiotics in both humans and animals, where the drugs are commonly used as a preventative measure or to stimulate growth.

Researchers from the University of Queensland, Queensland University of Technology and Bond University were tasked with finding a way to cut down on GP prescriptions and educate the public.